198 related articles for article (PubMed ID: 2424986)
41. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: determination of affinities and specificities of monoclonal antibodies by using biotin-labeled antibodies and avidin as precipitating agent in a solution phase immunoassay.
Wagener C; Clark BR; Rickard KJ; Shively JE
J Immunol; 1983 May; 130(5):2302-7. PubMed ID: 6187848
[TBL] [Abstract][Full Text] [Related]
42. Determination of the specificities of monoclonal antibodies recognizing members of the CEA family using a panel of transfectants.
Daniel S; Nagel G; Johnson JP; Lobo FM; Hirn M; Jantscheff P; Kuroki M; von Kleist S; Grunert F
Int J Cancer; 1993 Sep; 55(2):303-10. PubMed ID: 7690348
[TBL] [Abstract][Full Text] [Related]
43. Two CEA and three NCA species, although distinguishable by monoclonal antibodies, have nearly identical peptide patterns.
Grunert F; AbuHarfeil N; Schwarz K; von Kleist S
Int J Cancer; 1985 Sep; 36(3):357-62. PubMed ID: 3839768
[TBL] [Abstract][Full Text] [Related]
44. Purification and characterization of a 50,000 mol. wt glycoprotein antigen, and localization of determinants involved in cross-reactivity with carcinoembryonic antigen.
Laferté S; Krantz MJ
Mol Immunol; 1983 Apr; 20(4):421-31. PubMed ID: 6191208
[TBL] [Abstract][Full Text] [Related]
45. [Biliary carcinoembryonic antigen, non-specific cross-reacting antigen and biliary glycoprotein--their analysis and clinical aspects].
Yano Y
Nihon Geka Gakkai Zasshi; 1986 Nov; 87(11):1432-42. PubMed ID: 3537682
[TBL] [Abstract][Full Text] [Related]
46. Expression of carcinoembryonic or related cross-reacting antigens in primary pediatric neuroectodermal brain tumors.
Bodey B; Siegel SE; Peacock JS
Mod Pathol; 1992 Jul; 5(4):432-8. PubMed ID: 1323111
[TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma.
Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Yuba R; Mori M
Anticancer Res; 1989; 9(2):319-26. PubMed ID: 2751258
[TBL] [Abstract][Full Text] [Related]
48. Identification of a superficial bladder tumor-associated glycoform of the carcinoembryonic antigen by monoclonal antibody 19A211.
Bergeron A; LaRue H; Fradet Y
Cancer Res; 1996 Feb; 56(4):908-15. PubMed ID: 8631032
[TBL] [Abstract][Full Text] [Related]
49. Epitope mapping of the nonspecific cross-reacting antigen using various related recombinant proteins expressed in Chinese hamster ovary cells and eight distinct monoclonal antibodies.
Kuroki M; Haruno M; Murakami M; Wakisaka M; Oikawa S; Nakazato H; Matsuoka Y
Immunol Invest; 1992 Apr; 21(2):143-58. PubMed ID: 1374735
[TBL] [Abstract][Full Text] [Related]
50. Baculovirus recombinants expressing the human carcinoembryonic antigen gene.
Salgaller ML; Bei R; Schlom J; Poole DJ; Robbins PF
Cancer Res; 1993 May; 53(9):2154-61. PubMed ID: 8481918
[TBL] [Abstract][Full Text] [Related]
51. Immunochemical characterization of two antigens recognized by new monoclonal antibodies against human colon carcinoma.
Girardet C; Vacca A; Schmidt-Kessen A; Schreyer M; Carrel S; Mach JP
J Immunol; 1986 Feb; 136(4):1497-503. PubMed ID: 3944462
[TBL] [Abstract][Full Text] [Related]
52. Monoclonal antibody characterization of the 195-kilodalton major surface glycoprotein of Plasmodium falciparum malaria schizonts and merozoites: identification of additional processed products and a serotype-restricted repetitive epitope.
Lyon JA; Haynes JD; Diggs CL; Chulay JD; Haidaris CG; Pratt-Rossiter J
J Immunol; 1987 Feb; 138(3):895-901. PubMed ID: 2433334
[TBL] [Abstract][Full Text] [Related]
53. Major disagreements between immunoassays of carcinoembryonic antigen may be caused by nonspecific cross-reacting antigen 2 (NCA-2).
Börmer OP
Clin Chem; 1991 Oct; 37(10 Pt 1):1736-9. PubMed ID: 1914175
[TBL] [Abstract][Full Text] [Related]
54. Biochemical characterization of the molecules reactive with Qa-6 antiserum and the monoclonal antibody 20-8-4: evidence for structural similarity with the Qa-2 molecule.
Widacki SM; Flaherty L; Cook RG
J Immunol; 1985 Nov; 135(5):3333-9. PubMed ID: 2413118
[TBL] [Abstract][Full Text] [Related]
55. Immunological reactivity of mucinous and serous ovarian adenocarcinomas.
Harłozińska-Szmyrka A; Slesak B; Richter R; Rabczyński J; Cisło M
Cancer Detect Prev; 1986; 9(3-4):347-58. PubMed ID: 3017557
[TBL] [Abstract][Full Text] [Related]
56. Radioimmunotherapy for the intensification of conditioning before stem cell transplantation: differences in dosimetry and biokinetics of 188Re- and 99mTc-labeled anti-NCA-95 MAbs.
Kotzerke J; Glatting G; Seitz U; Rentschler M; Neumaier B; Bunjes D; Duncker C; Dohr D; Bergmann L; Reske SN
J Nucl Med; 2000 Mar; 41(3):531-7. PubMed ID: 10716329
[TBL] [Abstract][Full Text] [Related]
57. Epitope mapping of the carcinoembryonic antigen with various related recombinant proteins expressed in Chinese hamster ovary cells and 25 distinct monoclonal antibodies.
Ikeda S; Kuroki M; Haruno M; Oikawa S; Nakazato H; Kosaki G; Matsuoka Y
Mol Immunol; 1992 Feb; 29(2):229-40. PubMed ID: 1371822
[TBL] [Abstract][Full Text] [Related]
58. ["Non-specific cross reacting antigen (NCA)", a tracer of human granulocytes and monocytes].
Burtin P
C R Seances Soc Biol Fil; 1979; 173(2):261-9. PubMed ID: 92357
[TBL] [Abstract][Full Text] [Related]
59. Selection of a monoclonal antibody reactive with a high-molecular-weight glycoprotein circulating in the body fluid of gastrointestinal cancer patients.
Sakurai Y; Hirohashi S; Shimosato Y; Kodaira S; Abe O
Cancer Res; 1988 Jul; 48(14):4053-8. PubMed ID: 2454734
[TBL] [Abstract][Full Text] [Related]
60. Immunochemical identification of an alpha 1-acid glycoprotein-antigenic determinant on carcinoembryonic antigen (CEA) and non-specific cross-reacting antigen (NCA).
Ochi Y; Ura Y; Hamazu M; Fujiyama Y; Kajita Y; Ishida M; Miyazaki T; Tamura K
Clin Chim Acta; 1984 Mar; 138(1):9-19. PubMed ID: 6201306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
